IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Modern Diagnostic & Research Centre IPO is a Book Building IPO listing on BSE SME exchange. The company is based in New Delhi and caters to Healthcare - Hospitals And Clinic sector. Beeline Capital Advisors is the merchant banker of Modern Diagnostic & Research Centre IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st March 2025.
Modern Diagnostic & Research Centre IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
35.35 cr.
Sector: Healthcare - Hospitals And Clinic
SME IPO so far:
13
Merchant Banker:
Beeline Capital
SME IPO by BRLM so far:
73
City:
New Delhi
SME IPO so far:
57
Revenue (annualised):
₹
80.66
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 24.63x
Modern Diagnostic & Research Centre IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Beeline Capital Advisors Private Limited is the book-running lead manager of the Modern Diagnostic & Research Centre IPO. Link Intime India Private Limited is the Registrar for Modern Diagnostic & Research Centre IPO.
Modern Diagnostic & Research Centre IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 35.35 Cr.
Sector: Healthcare - Hospitals And Clinic
SME IPO so far:
13
Merchant Banker:
Beeline Capital
SME IPO by BRLM so far:
73
City:
New Delhi
SME IPO so far:
57
Revenue (annualised):
₹ 80.66 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 24.63x
Modern Diagnostic & Research Centre IPO, based in New Delhi, operates in the Healthcare - Hospitals And Clinic sector with a focus on Provides reliable diagnostic tests. The company is launching its SME UPCOMING IPO on the BSE SME exchange, using the Book Building Issue method. Modern Diagnostic & Research Centre IPO size is ₹ [●] Crores with fresh issue size of ₹ [●] Crores and Offer for sale being Nil.
The IPO allotment date for Modern Diagnostic & Research Centre IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Modern Diagnostic & Research Centre IPO allotment status on the registrars website, Link Intime India Private Limited. Modern Diagnostic & Research Centre IPO refund dates are [●].
Modern Diagnostic & Research Centre IPO is expected to be listed on [●].
The upper price band for the Modern Diagnostic & Research Centre IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Modern Diagnostic & Research Centre IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Modern Diagnostic & Research Centre IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Modern Diagnostic & Research Centre IPO is finalised.
The merchant banker for Modern Diagnostic & Research Centre IPO is Beeline Capital Advisors Private Limited . Beeline Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Modern Diagnostic & Research Centre IPO RHP for further details.
The registrar for Modern Diagnostic & Research Centre IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Modern Diagnostic & Research Centre IPO through their official website or helpline.
Modern Diagnostic & Research Centre IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Modern Diagnostic & Research Centre IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Modern Diagnostic & Research Centre Financial Review Page
Merchant Banker(s) of Modern Diagnostic & Research Centre IPO: Beeline Capital Advisors Private Limited
Modern Diagnostic & Research Centre IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Modern Diagnostic & Research Centre IPO listed at a listing price of against the offer price of .
The current market price of Modern Diagnostic & Research Centre is .
Why Us?
